|
CLEC16A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.26330000016495E-07 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.940360E-01 |
| Stage1-vs-Stage3 |
4.728600E-01 |
| Stage1-vs-Stage4 |
1.197970E-01 |
| Stage2-vs-Stage3 |
4.479000E-01 |
| Stage2-vs-Stage4 |
2.698000E-02 |
| Stage3-vs-Stage4 |
6.625800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.79320000004424E-06 |
| Normal-vs-Asian |
2.2429835766502E-12 |
| Caucasian-vs-AfricanAmerican |
4.417400E-01 |
| Caucasian-vs-Asian |
5.376400E-01 |
| AfricanAmerican-vs-Asian |
7.880800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
2.123600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62647673107585E-12 |
| Normal-vs-Age(81-100Yrs) |
8.495300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.867200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.834000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.313970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.603820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.479600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.643600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.290200E-01 |
| Classical-VS-Follicular |
1.11022302462516E-16 |
| Classical-VS-Other |
1.409450E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
7.77929999973281E-07 |
| Tall-VS-Other |
1.293370E-01 |
| Tall-VS-Normal |
3.16724424465065E-12 |
| Follicular-VS-Other |
1.751010E-01 |
| Follicular-VS-Normal |
5.189500E-04 |
| Other-VS-Normal |
1.471520E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.26108021195159E-12 |
| N0-vs-N1 |
1.819580E-01 |
|
|
